Open Access

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Presentation

About the speaker

Doctor Matthew Cavender

University of North Carolina Hospitals, Chapel Hill (United States of America)
5 presentations
0 follower

3 more presentations in this session

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Speaker: Doctor M. Husain (Toronto, CA)

Thumbnail

Glucagon-like peptide 1 receptor agonist use in cardiology.

Speaker: Professor M. Petrie (Glasgow, GB)

Thumbnail

Live panel discussion.

Thumbnail

Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Doctor M. Cavender, Doctor M. Husain, Professor M. Petrie
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Using a digital tool to solve organizational challenges in the Heart Failure team.

22 October 2021

ESC Premium Access

COVID-19 & digital health: techcelleration here to stay?

22 October 2021

ESC Premium Access

The ESC journey and future directions.

22 October 2021

This platform is supported by

logo Novo Nordisk